1. Home
  2. USA vs VCEL Comparison

USA vs VCEL Comparison

Compare USA & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

USA

Liberty All-Star Equity Fund

HOLD

Current Price

$5.63

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$32.29

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USA
VCEL
Founded
N/A
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
USA
VCEL
Price
$5.63
$32.29
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$58.50
AVG Volume (30 Days)
1.1M
446.2K
Earning Date
01-01-0001
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.00
EPS
N/A
0.32
Revenue
N/A
$276,259,000.00
Revenue This Year
N/A
$19.09
Revenue Next Year
N/A
$17.96
P/E Ratio
N/A
$100.34
Revenue Growth
N/A
16.45
52 Week Low
$5.64
$29.24
52 Week High
$6.96
$48.75

Technical Indicators

Market Signals
Indicator
USA
VCEL
Relative Strength Index (RSI) 24.52 34.04
Support Level N/A $31.34
Resistance Level $6.66 $38.48
Average True Range (ATR) 0.07 1.41
MACD -0.03 -0.37
Stochastic Oscillator 1.27 15.85

Price Performance

Historical Comparison
USA
VCEL

About USA Liberty All-Star Equity Fund

Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: